Jiangsu Chinagreen Biological Technology Group Co.,Ltd. (SHE:300970)
China flag China · Delayed Price · Currency is CNY
12.46
+0.12 (0.97%)
At close: Oct 28, 2026

SHE:300970 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Operating Revenue
1,4231,2921,032996.22751.58578.08
Other Revenue
00--0.020
1,4231,2921,032996.22751.59578.09
Revenue Growth
22.23%25.17%3.60%32.55%30.01%-5.14%
Cost of Revenue
1,2131,084982.52870.12632.47539.94
Gross Profit
209.96207.7549.59126.1119.1238.15
Selling, General & Admin
85.9668.878.3780.1849.2937.25
Research & Development
22.0417.3714.6116.5314.048.62
Other Operating Expenses
-8.87-8.92-8.23-7.910.530.41
Operating Expenses
98.8677.1786.3589.3264.2946.72
Operating Income
111.1130.58-36.7636.7854.83-8.58
Interest Expense
-20.19-15.97-11.18-8.75-2.69-3.83
Interest & Investment Income
16.397.443.379.1816.716.21
Currency Exchange Gain (Loss)
-----0
Other Non Operating Income (Expenses)
-0.1-0.19-0.341.8-0.39-0.2
EBT Excluding Unusual Items
107.21121.86-44.9139.0168.443.6
Gain (Loss) on Sale of Investments
----0.17-0.060.24
Gain (Loss) on Sale of Assets
-4.29-2.15-1.48-10.89-1.33-0.26
Asset Writedown
-8.45-0.67-0.4-3.57-0.36-
Other Unusual Items
0.720.262.51213.2913.21
Pretax Income
95.19119.31-44.2826.3779.9916.79
Income Tax Expense
00.050.1502.320.51
Earnings From Continuing Operations
95.19119.26-44.4226.3777.6716.28
Minority Interest in Earnings
-20.22-8.99-3.143.980.59-0.78
Net Income
74.98110.27-47.5730.3578.2515.5
Net Income to Common
74.98110.27-47.5730.3578.2515.5
Net Income Growth
1843.48%---61.22%404.70%-88.30%
Shares Outstanding (Basic)
183154151152152144
Shares Outstanding (Diluted)
183154151152152144
Shares Change
45.26%2.21%-0.62%-0.06%5.46%8.65%
EPS (Basic)
0.410.72-0.320.200.520.11
EPS (Diluted)
0.410.72-0.320.200.520.11
EPS Growth
1237.93%---61.20%378.55%-89.23%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Free Cash Flow
234.05222.19-130.42-57.48-228.07-121.01
Free Cash Flow Per Share
1.281.44-0.86-0.38-1.50-0.84
Dividend Per Share
0.3850.385-0.1540.154-
Dividend Growth
---0%-23.10%-
Gross Margin
14.75%16.08%4.81%12.66%15.85%6.60%
Operating Margin
7.81%10.11%-3.56%3.69%7.29%-1.48%
Profit Margin
5.27%8.54%-4.61%3.05%10.41%2.68%
Free Cash Flow Margin
16.45%17.20%-12.64%-5.77%-30.34%-20.93%
EBITDA
294.66295.88104.19154.31151.7975.92
EBITDA Margin
20.71%22.90%10.10%15.49%20.20%13.13%
D&A For EBITDA
183.56165.3140.95117.5396.9684.49
EBIT
111.1130.58-36.7636.7854.83-8.58
EBIT Margin
7.81%10.11%-3.56%3.69%7.29%-1.48%
Effective Tax Rate
0.00%0.04%--2.90%3.02%
Revenue as Reported
1,4231,2921,032996.22751.59578.09
Advertising Expenses
-0.140.450.260.030.89